Clinical Trials · NCT04190160
Quality of Life and Fixed-ratio Combination of Insulin Degludec and Liraglutide (iDegLira)
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Stefano Rizza
- Enrollment
- 35
- Start date
- Nov 2018
- Locations
- 1 site, Italy
- Primary endpoint
- Self reported quality of Life (CASP-19)